跳至主要内容
临床试验/NCT00965302
NCT00965302终止不适用

Sleeve Gastrectomy vs Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients

59th Medical Wing2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
50
试验地点
2
主要终点
Diabetes remission

研究概览

简要总结

The investigators plan to randomize mild to moderately obese (BMI 30-34.9) subjects to medical management (diet, exercise, and best medical therapy) versus sleeve gastrectomy with medical management, with a primary endpoint of diabetes remission (normal fasting glucose, off medications and insulin) at one year. Sleeve gastrectomy (also called greater curvature gastrectomy, vertical sleeve gastrectomy, and sleeve gastroplasty) involves stapled resection of the gastric fundus. Secondary endpoints include weight loss, improvement in hypertension, sleep apnea, c-reactive protein, and fasting lipid profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes mellitus, Type 2
  • Body Mass Index (BMI) 30-34.9
  • Able to understand and comply with study process

排除标准

  • Pregnancy
  • Prior bariatric surgery
  • Diabetes mellitus, Type 1
  • Renal impairment
  • Cirrhosis or portal hypertension
  • Diabetes secondary to a specific condition
  • Recent internal malignancy (<5 years)
  • Recent major vascular event
  • Drug or alcohol dependence
  • Uncontrolled psychiatric disease
  • Crippling cardiopulmonary disease
  • Prohibitive anatomic features (extensive prior surgery, giant paraesophageal hernia)

结局指标

主要结局

Diabetes remission

时间窗: 1 year

次要结局

  • c-reactive protein(1 year)
  • Fasting lipid profile(1 year)
  • Weight loss(1 year)
  • Obstructive sleep apnea remission(1 year)

研究者

申办方类型
Fed

研究点 (2)

Loading locations...

相似试验